DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Mono Pharmacare Limited — Outcome of Board Meeting

NSE 2 hrs ago·3 Sept 2026, 1:07 pm

Mono Pharmacare

Mono Pharmacare Limited has announced the outcome of its board meeting held on September 03, 2026. The company has submitted a regulatory filing to the stock exchange regarding the proceedings of this session.

For investors, this update is primarily a procedural disclosure. It confirms that the company’s highest decision-making body has convened and concluded its business for the specified date. Such filings are standard practice for publicly traded entities to ensure transparency regarding corporate governance activities.

Investors should monitor the exchange filing for any specific details regarding agenda items discussed, such as strategic decisions, financial approvals, or future corporate actions. Until the full details are disclosed, the market will view this as a routine governance update.